VIRGINIA COMMONWEALTH UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1838-01-01

Employees: 10K

Market Cap: -

Website: http://www.vcu.edu

Clinical Trials

Erythromycin in Parkinson's Disease

Not Applicable

Completed

Conditions: Parkinson's Disease
Levodopa

Interventions: Drug: placebo
Drug: Erythromycin

First Posted Date: 2013-12-09

Last Posted Date: 2017-02-03

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 18

Registration Number: NCT02005029

Locations: 🇺🇸
Virginia Commonwealth University Parkinson's Center, Richmond, Virginia, United States

Dietary and Exercise Interventions in Preventing Cardiovascular Disease in Younger Survivors of Leukemia, Lymphoma, or Brain Tumors

Not Applicable

Withdrawn

Conditions: Childhood Brain Tumor
Childhood Non-Hodgkin Lymphoma
Childhood Hodgkin Lymphoma
Malignant Childhood Neoplasm

Interventions: Behavioral: Specimen Collection/Risk Factor Assessment -> Diet/Exercise -> Chemotherapy

First Posted Date: 2013-12-04

Last Posted Date: 2015-11-20

Lead Sponsor: Virginia Commonwealth University

Registration Number: NCT02000986

Pilot Study of Laparoscopic Gastric Plication in Adolescents With Severe Obesity

Not Applicable

Completed

Conditions: Obesity

Interventions: Procedure: Laparoscopic Gastric Plication

First Posted Date: 2013-11-11

Last Posted Date: 2018-07-10

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 4

Registration Number: NCT01980758

Locations: 🇺🇸
Children's Hospital of Richmond at VCU, Richmond, Virginia, United States

Safety and Efficacy of IMM 124-E for Patients With Severe Alcoholic Hepatitis

Phase 2

Completed

Conditions: Hepatitis, Alcoholic

Interventions: Drug: IMM 124-E (Hyperimmune Bovine Colostrum)
Drug: Placebo (High protein milk powder)

First Posted Date: 2013-10-24

Last Posted Date: 2020-01-27

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 57

Registration Number: NCT01968382

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇺🇸
Indiana University, Indianapolis, Indiana, United States
🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Interleukin-1 (IL-1) Blockade in Acute Myocardial Infarction (VCU-ART3)

Phase 2

Completed

Conditions: Acute Myocardial Infarction

Interventions: Drug: Anakinra 100 mg
Drug: Placebo

First Posted Date: 2013-09-25

Last Posted Date: 2019-12-18

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 99

Registration Number: NCT01950299

Locations: 🇺🇸
Washington Hospital Center, Washington, District of Columbia, United States
🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Intestinal Ischemia as a Stimulus for Systemic Inflammatory Response After Cardiac Arrest

Completed

Conditions: Reperfusion Injury
Cardiac Arrest

First Posted Date: 2013-09-17

Last Posted Date: 2017-10-06

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 40

Registration Number: NCT01944605

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Interleukin-1 Blockade in Recently Decompensated Heart Failure

Phase 2

Completed

Conditions: Heart Failure

Interventions: Drug: Anakinra (weeks 1-2)
Drug: Placebo
Drug: Anakinra (weeks 3-12)

First Posted Date: 2013-09-06

Last Posted Date: 2017-12-22

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 60

Registration Number: NCT01936909

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Interleukin (IL)-1 Blockade in Acute Heart Failure (Anakinra ADHF)

Phase 2

Completed

Conditions: Heart Failure

Interventions: Drug: Anakinra (high dose)
Drug: Placebo
Drug: Anakinra (standard dose)

First Posted Date: 2013-09-06

Last Posted Date: 2016-05-05

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 30

Registration Number: NCT01936844

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Alpha-1 Anti-Trypsin (AAT) Treatment in Acute Myocardial Infarction

Phase 1

Completed

Conditions: Acute Myocardial Infarction

Interventions: Drug: Alpha 1-Antitrypsin

First Posted Date: 2013-09-06

Last Posted Date: 2016-02-12

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 10

Registration Number: NCT01936896

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

Evaluation of a Skill-Building, Supportive, and Educational Intervention for Couples

Not Applicable

Completed

Conditions: Traumatic Brain Injury
Acquired Brain Injury

Interventions: Behavioral: Couples counseling

First Posted Date: 2013-09-05

Last Posted Date: 2017-10-27

Lead Sponsor: Virginia Commonwealth University

Target Recruit Count: 160

Registration Number: NCT01935609

Locations: 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy